ARCEDI BIOTECH APS

Company Snapshot

Founded: 2013

Entity Type: Private

Region: Denmark

Headquarter: Denmark

Key Geographics: Europe

Corporate Address: Tabletvej 1 7100 Vejle Denmark Tel. +45-49-28-88-88 www.arcedi.com

Company Overview

Arcedi Biotech ApS, founded in 2013, is developing a cell-based NIPT diagnostic platform that targets pure fetal DNA for analysis. Arcedi’s platform employs a unique cell capture technology that employs several antibodies against markers. The markers are proprietary and represent a key asset of the company.

After cell capture, the Arcedi platform uses an algorithm for identifying fetal cells under a fluorescence scanner. After individual cells are selected, DNA is amplified and analyzed by either aCGH or NGS.

Advantages of the cell-based NIPT include identification of additional disorders than those covered by cell free-based NIPT. This includes disorders that may be passed on to the fetus from the mother.

ARCEDI BIOTECH APS In Reports

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Discover BCC Research's report on Next-generation Sequencing Market is steadily being integrated into clinical laboratory analysis, testing, and disease diagnostics in healthcare sectors globally.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

BCC Research Market Report says clinical next-generation sequencing (NGS) should grow from $5.9 billion in 2020 to $22.9 billion by 2025 with a (CAGR) of 31.4%.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

BCC Market Research Report for global liquid biopsy research tools, liquid biopsy biomarkers, technologies, services and diagnostics markets.

View All Reports

ARCEDI BIOTECH APS In News

Hydatidiform mole diagnostics using circulating gestational trophoblasts isolated from maternal blood - Wiley Online Library

Wiley Online Library - Dec 11, 2020

Company's Business Segments

Cell Diagnosis : The company develops technologies for cell-based noninvasive prenatal diagnosis (cbNIPD).

Applications/End User Industries

Healthcare

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment